Evidence map›Paper›PMID 23107433›Full record

ArticleNeurobiology of aging2013

Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians.

Martin A Kohli, Krista John-Williams, Ruchita Rajbhandary, Adam Naj, Patrice Whitehead, Kara Hamilton, Regina M Carney, Clinton Wright, Elizabeth Crocco, Harry E Gwirtzman and 11 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Frontiers in genetics · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetics of dementia in a Finnish cohort.European journal of human genetics : EJHG · 2018
    Article
  18. C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias.Movement disorders : official journal of the Movement Disorder Society · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Martin A KohliJohn P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. mkohli@med.miami.edu
Krista John-Williams
Ruchita Rajbhandary
Adam Naj
Patrice Whitehead
Kara Hamilton
Regina M Carney
Clinton Wright
Elizabeth Crocco
Harry E Gwirtzman
Rosalyn Lang
Gary Beecham
Eden R Martin
John Gilbert
Michael Benatar
Gary W Small
Deborah Mash
Goldie Byrd
Jonathan L Haines
Margaret A Pericak-Vance
Stephan Züchner
University of Miami · USDr. John T. Macdonald Foundation · USCenter for Human Genetics · USNorth Carolina Agricultural and Technical State University · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Genetic Studies of Dementia in the AmishR01AG019085 · NIA · VANDERBILT UNIVERSITY · PI HAINES, JONATHAN L · 2001 to 2011
$11.0M
Genetic Epidemiology of Alzheimer's Disease in African AmericansR01AG028786 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MANLY, JENNIFER JAIE · 2007 to 2011
$7.3M
Genomic Convergence in Alzheimer DiseaseR01AG027944 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PERICAK-VANCE, MARGARET A. · 2008 to 2012
$5.9M
Genome Wide associate analysis of Alzheimer's DiseaseRC2AG036528 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2010
$5.4M
NCATS NIH HHS UL1 TR000124NIA NIH HHS 5R01 AG028786-04NIA NIH HHS R01 AG019085NIA NIH HHS R01 AG027944NIA NIH HHS R01 AG028786NIA NIH HHS R01 AG028786-02NIA NIH HHS RC2 AG036528NIA NIH HHS RC2AG036528NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886
6 · The paper itself

Abstract

Recently, a hexanucleotide repeat expansion in the C9ORF72 gene has been identified to account for a significant portion of Caucasian families affected by frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Given the clinical overlap of FTD with Alzheimer's disease (AD), we hypothesized that C9ORF72 expansions might contribute to AD. In Caucasians, we found C9ORF72 expansions in the pathogenic range of FTD/ALS (>30 repeats) at a proportion of 0.76% in AD cases versus 0 in control subjects (p = 3.3E-03; 1182 cases, 1039 controls). In contrast, no large expansions were detected in individuals of African American ethnicity (291 cases, 620 controls). However, in the range of normal variation of C9ORF72 expansions (0-23 repeat copies), we detected significant differences in distribution and mean repeat counts between Caucasians and African Americans. Clinical and pathological re-evaluation of identified C9ORF72 expansion carriers revealed 9 clinical and/or autopsy confirmed AD and 2 FTD final diagnoses. Thus, our results support the notion that large C9ORF72 expansions lead to a phenotypic spectrum of neurodegenerative disease including AD.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseC9orf72 ProteinComorbidityDNA Repeat ExpansionFemaleFrontotemporal DementiaGenetic MarkersGenetic Predisposition to DiseaseGenetic TestingHumansMaleMiddle AgedPrevalenceProteinsC9orf72 ProteinC9orf72 protein, humanGenetic MarkersProteins

Identifiers

PMID23107433
PMCPMC3586789
OpenAlexW2028580880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.